Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

pyridomycin

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Antimicrobial resistance (AMR) is a global public health threat that warrants urgent attention. However, the multifaceted nature… Expand
  • table 1
2016
2016
Pyridomycin is an antimycobacterial cyclodepsipeptide assembled by a nonribosomal peptide synthetase/polyketide synthase hybrid… Expand
2014
2014
Pyridomycin, a natural product with potent antituberculosis activity, inhibits a major drug target, the InhA enoyl reductase… Expand
  • figure 1
  • figure 2
  • figure 3
2013
2013
Dihydropyridomycins 2 and 3, which lack the characteristic enol ester moiety of the potent antimycobacterial natural product… Expand
  • table 1
Highly Cited
2012
Highly Cited
2012
Tuberculosis, a global threat to public health, is becoming untreatable due to widespread drug resistance to frontline drugs such… Expand
2011
2011
Pyridomycin is a structurally unique antimycobacterial cyclodepsipeptide containing rare 3-(3-pyridyl)-l-alanine and 2-hydroxy-3… Expand
2011
2011
Pyridomycin is a structurally unique antimycobacterial cyclodepsipeptide containing rare 3-(3-pyridyl)-L-alanine and 2-hydroxy-3… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
1968
1968
Structural studies on pyridomycin have been performed by chemical degradation such as ozonolysis and hydrolysis in alkaline and… Expand
1968
1968
 
1953
1953